Tango Therapeutics Stock (NASDAQ: TNGX) stock price, news, charts, stock research, profile.
Open | $9.72 |
Close | $9.75 |
Volume / Avg. | 828.47K / 726.28K |
Day Range | 9.65 - 10.05 |
52 Wk Range | 2.88 - 13.03 |
Market Cap | $1.04B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 14.43% |
Days to Cover | 6.93 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tango Therapeutics (NASDAQ:TNGX) through any online brokerage.
Other companies in Tango Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Cogent Biosciences (NASDAQ:COGT) and Centessa Pharmaceuticals (NASDAQ:CNTA).
There is no analysis for Tango Therapeutics.
Tango Therapeutics has a consensus price target of $16.20.
The stock price for Tango Therapeutics (NASDAQ: TNGX) is $9.69 last updated July 23, 2024 at 7:01 PM EDT.
There are no upcoming dividends for Tango Therapeutics.
Tango Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Tango Therapeutics.
Tango Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.